IDEAYA Biosciences(IDYA)
Focus: IDEAYA Biosciences is a public oncology-focused biotech developing personalized synthetic medicines using precision medicine approaches. The company operates at mid-cap scale (501-1,000 employees) with a pure-play R&D model centered on targeted cancer therapies.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
501-1000
Open Jobs
20-4 this month
Stable — net -4 jobs in 30d
2 added, 6 removed. Backfill posture.
Should You Work at IDEAYA Biosciences?
AI assessmentHigh-risk, high-reward opportunity best suited for scientists/clinical professionals comfortable with preclinical/early clinical emphasis and biotech volatility.
Why Work Here
- Pure oncology focus with 10 active pipeline programs spanning Phase 1-3, including Phase 3 lead Darovasertib in uveal melanoma with clear near-term catalysts
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$23M
Pipeline & Clinical Trials
PHASE_1
IDE892
NSCLC AdenocarcinomaClinical Trials (1)
Help build intelligence for IDEAYA Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.